CLRB Annual Shareholders Equity
-$15.16 M
-$23.31 M-285.93%
31 December 2023
Summary:
As of January 23, 2025, CLRB annual stockholders equity is -$15.16 million, with the most recent change of -$23.31 million (-285.93%) on December 31, 2023. During the last 3 years, it has fallen by -$69.95 million (-127.67%). CLRB annual shareholders equity is now -127.67% below its all-time high of $54.79 million, reached on December 31, 2020.CLRB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLRB Quarterly Shareholders Equity
$15.16 M
+$2.78 M+22.49%
30 September 2024
Summary:
As of January 23, 2025, CLRB quarterly stockholders equity is $15.16 million, with the most recent change of +$2.78 million (+22.49%) on September 30, 2024. Over the past year, it has increased by +$30.32 million (+200.04%). CLRB quarterly shareholders equity is now -72.32% below its all-time high of $54.79 million, reached on December 31, 2020.CLRB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLRB Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -285.9% | +200.0% |
| 3 y3 years | -127.7% | -60.7% |
| 5 y5 years | -214.3% | +24.0% |
CLRB Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -145.9% | at low | -54.1% | +200.0% |
| 5 y | 5-year | -127.7% | at low | -72.3% | +200.0% |
| alltime | all time | -127.7% | +43.6% | -72.3% | +156.4% |
Cellectar Biosciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $15.16 M(+22.5%) |
| June 2024 | - | $12.38 M(-52.7%) |
| Mar 2024 | - | $26.17 M(-272.6%) |
| Dec 2023 | -$15.16 M(-285.9%) | -$15.16 M(+13.5%) |
| Sept 2023 | - | -$13.35 M(+2759.3%) |
| June 2023 | - | -$467.00 K(-106.4%) |
| Mar 2023 | - | $7.33 M(-10.0%) |
| Dec 2022 | $8.15 M(-75.3%) | $8.15 M(-36.1%) |
| Sept 2022 | - | $12.75 M(-36.9%) |
| June 2022 | - | $20.19 M(-25.8%) |
| Mar 2022 | - | $27.21 M(-17.7%) |
| Dec 2021 | $33.05 M(-39.7%) | $33.05 M(-14.4%) |
| Sept 2021 | - | $38.59 M(-12.3%) |
| June 2021 | - | $43.98 M(-11.6%) |
| Mar 2021 | - | $49.78 M(-9.2%) |
| Dec 2020 | $54.79 M(+504.8%) | $54.79 M(+237.7%) |
| Sept 2020 | - | $16.22 M(-18.8%) |
| June 2020 | - | $19.99 M(+281.0%) |
| Mar 2020 | - | $5.25 M(-42.1%) |
| Dec 2019 | $9.06 M(-31.7%) | $9.06 M(-25.9%) |
| Sept 2019 | - | $12.23 M(-23.5%) |
| June 2019 | - | $15.99 M(+62.3%) |
| Mar 2019 | - | $9.85 M(-25.7%) |
| Dec 2018 | $13.26 M(+23.3%) | $13.26 M(-21.4%) |
| Sept 2018 | - | $16.88 M(+258.6%) |
| June 2018 | - | $4.71 M(-36.8%) |
| Mar 2018 | - | $7.45 M(-30.7%) |
| Dec 2017 | $10.75 M(-20.6%) | $10.75 M(+41.6%) |
| Sept 2017 | - | $7.59 M(-30.1%) |
| June 2017 | - | $10.86 M(-21.0%) |
| Mar 2017 | - | $13.75 M(+1.5%) |
| Dec 2016 | $13.54 M(+720.7%) | $13.54 M(+75.5%) |
| Sept 2016 | - | $7.72 M(-21.5%) |
| June 2016 | - | $9.83 M(+281.5%) |
| Mar 2016 | - | $2.58 M(+56.2%) |
| Dec 2015 | $1.65 M(-75.4%) | $1.65 M(+142.5%) |
| Sept 2015 | - | $680.20 K(-71.3%) |
| June 2015 | - | $2.37 M(-48.3%) |
| Mar 2015 | - | $4.59 M(-31.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $6.70 M(+294.1%) | $6.70 M(-49.1%) |
| Sept 2014 | - | $13.15 M(-617.6%) |
| June 2014 | - | -$2.54 M(+249.3%) |
| Mar 2014 | - | -$727.30 K(-142.8%) |
| Dec 2013 | $1.70 M(-83.3%) | $1.70 M(-61.6%) |
| Sept 2013 | - | $4.43 M(-18.7%) |
| June 2013 | - | $5.44 M(-23.7%) |
| Mar 2013 | - | $7.13 M(-29.8%) |
| Dec 2012 | $10.16 M(+7.1%) | $10.16 M(+12.0%) |
| Sept 2012 | - | $9.07 M(-14.7%) |
| June 2012 | - | $10.63 M(+40.6%) |
| Mar 2012 | - | $7.56 M(-20.2%) |
| Dec 2011 | $9.48 M(+6986.0%) | $9.48 M(+60.8%) |
| Sept 2011 | - | $5.90 M(-20.4%) |
| June 2011 | - | $7.41 M(+2329.7%) |
| Mar 2011 | - | $304.90 K(+127.9%) |
| Dec 2010 | $133.80 K(-100.5%) | $133.80 K(-100.8%) |
| Sept 2010 | - | -$17.02 M(+5.7%) |
| June 2010 | - | -$16.10 M(+13.1%) |
| Mar 2010 | - | -$14.23 M(-47.1%) |
| Dec 2009 | -$26.90 M(+38.0%) | -$26.90 M(+21.1%) |
| Sept 2009 | - | -$22.20 M(-12.4%) |
| June 2009 | - | -$25.33 M(-1536.8%) |
| Mar 2009 | - | $1.76 M(-109.0%) |
| Dec 2008 | -$19.49 M(+232.0%) | -$19.49 M(+15.7%) |
| Sept 2008 | - | -$16.84 M(+0.0%) |
| June 2008 | - | -$16.84 M(+26.7%) |
| Mar 2008 | - | -$13.29 M(+126.3%) |
| Dec 2007 | -$5.87 M(-155.3%) | -$5.87 M(-153.7%) |
| Sept 2007 | - | $10.92 M(+41.7%) |
| June 2007 | - | $7.71 M(-7.4%) |
| Mar 2007 | - | $8.33 M(-21.5%) |
| Dec 2006 | $10.61 M(+124.7%) | $10.61 M(-19.8%) |
| Sept 2006 | - | $13.22 M(-17.2%) |
| June 2006 | - | $15.97 M(-8.3%) |
| Mar 2006 | - | $17.42 M(+269.0%) |
| Dec 2005 | $4.72 M | $4.72 M(-5.5%) |
| Sept 2005 | - | $4.99 M(+329.8%) |
| June 2005 | - | $1.16 M(-1116.4%) |
| Mar 2005 | - | -$114.30 K |
FAQ
- What is Cellectar Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Cellectar Biosciences?
- What is Cellectar Biosciences annual shareholders equity year-on-year change?
- What is Cellectar Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly shareholders equity year-on-year change?
What is Cellectar Biosciences annual stockholders equity?
The current annual shareholders equity of CLRB is -$15.16 M
What is the all time high annual shareholders equity for Cellectar Biosciences?
Cellectar Biosciences all-time high annual stockholders equity is $54.79 M
What is Cellectar Biosciences annual shareholders equity year-on-year change?
Over the past year, CLRB annual stockholders equity has changed by -$23.31 M (-285.93%)
What is Cellectar Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of CLRB is $15.16 M
What is the all time high quarterly shareholders equity for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly stockholders equity is $54.79 M
What is Cellectar Biosciences quarterly shareholders equity year-on-year change?
Over the past year, CLRB quarterly stockholders equity has changed by +$30.32 M (+200.04%)